June 23, 2025

Mapping Tumor DNA May Advance Personalized Brain Cancer Treatments

A new study from City of Hope researchers has identified how mapping the genetic material surrounding chromosomes in brain tumors may help physicians develop more personalized therapies for patients with glioma, a type of brain cancer.

Conexiant

June 23, 2025

What’s the Dose for Hair Regrowth?

A national survey found wide variation in intralesional corticosteroid injection techniques among US hair specialists treating different types of alopecia.

Conexiant

June 23, 2025

Surgical Technique During Prostatectomy Predicts Erectile Recovery

A multi-institutional study found that specific intraoperative techniques and technical skills during robotic-assisted prostatectomy were linked to erectile function recovery one year after surgery.

Conexiant

June 23, 2025

STING Deletion Attenuates Amyloid Beta Pathology

Genetic deletion of STING in a mouse model of Alzheimer’s disease reduced amyloid plaque accumulation, suppressed neuroinflammatory responses, and improved memory, highlighting STING’s role in disease progression and potential as a therapeutic target.

Conexiant

June 23, 2025

Older Adults Lead Vaccine Comeback

Older Americans are embracing vaccines—backed by new research confirming enhanced safety, disease prevention, and even a potential link to reduced dementia risk.

KFF Health News

June 19, 2025

Single Psilocybin Dose Yields Long-Term Cancer Relief

A single psilocybin dose combined with therapy led to lasting reductions in depression and anxiety for cancer patients two years after treatment, according to new research.

Conexiant

June 16, 2025

New Tool Estimates Amyloid Risk in Early Alzheimer’s

Cognitive performance–based score stratifies older adults by risk of cerebral amyloid deposition.

Conexiant

June 12, 2025

Medical Oddities: 6 Foot Moves Possibly Worth Prescribing

Strong feet, smarter carbs, test kits, and tea—this roundup’s got range.

Conexiant

June 12, 2025

Four Toxins Tested for Glabellar Wrinkle Duration

A new randomized trial using 3D imaging compared four botulinum toxin A formulations in women, revealing differences in onset and durability of glabellar wrinkle reduction over six months.

Conexiant